Cancer Institute A national cancer institute
designated cancer center

Joseph Shrager

Publication Details

  • Treatment of refractory, nonmalignant hydrothorax with a pleurovenous shunt.

    Park SZ, Shrager JB, Allen MS, Nagorney DM. Ann Thorac Surg. 1997; 63 (6): 1777-9

    We present a case of long-term successful application of pleurovenous shunting for the management of pleural effusion. Intractable symptomatic hydrothorax developed as a result of transdiaphragmatic migration of hepatic ascites. After failure of traditional treatment by mechanical pleurodesis, a pleurovenous shunt was inserted. After 1 year of follow-up, the effusion is well controlled, and the shunt remains patent.

    PubMedID: 9205188

Stanford Medicine Resources:

Footer Links: